THIOPURINE-METHYL-TRANSFERASE ACTIVITY TO ASSESS AZATHIOPRINE MYELOTOXICITY IN RENAL-TRANSPLANT RECIPIENTS

被引:30
作者
SORIAROYER, C
LEGENDRE, C
MIRCHEVA, J
PREMEL, S
BEAUNE, P
KREIS, H
机构
关键词
D O I
10.1016/0140-6736(93)90729-Z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1593 / 1594
页数:2
相关论文
共 4 条
[1]   THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS [J].
CHOCAIR, PR ;
DULEY, JA ;
SIMMONDS, HA ;
CAMERON, JS .
TRANSPLANTATION, 1992, 53 (05) :1051-1056
[2]   PHARMACOGENETICS OF ACUTE AZATHIOPRINE TOXICITY - RELATIONSHIP TO THIOPURINE METHYLTRANSFERASE GENETIC-POLYMORPHISM [J].
LENNARD, L ;
VANLOON, JA ;
WEINSHILBOUM, RM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :149-154
[3]   AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN THIOPURINE METHYLTRANSFERASE DEFICIENT HEART-TRANSPLANT RECIPIENT [J].
SCHUTZ, E ;
GUMMERT, J ;
MOHR, F ;
OELLERICH, M .
LANCET, 1993, 341 (8842) :436-436
[4]  
WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651